Medipharm Labs CorpOTCQB:MEDIFView on Canadian Exchange
- LAST PRICE0.0528
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close--- / 0.0528
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MEDIF |
|---|---|---|
| 09:32 ET | 400 | 0.053 |
| 09:33 ET | 582 | 0.0574 |
| 09:35 ET | 10691 | 0.061 |
| 09:46 ET | 21093 | 0.0575 |
| 10:09 ET | 200000 | 0.05 |
| 10:51 ET | 3201 | 0.0524 |
| 11:14 ET | 1804 | 0.0555 |
| 11:23 ET | 727 | 0.0555 |
| 11:32 ET | 1078 | 0.0576 |
| 11:43 ET | 5000 | 0.0543 |
| 11:45 ET | 428 | 0.0548 |
| 01:27 ET | 5468 | 0.0548 |
| 01:51 ET | 100 | 0.0552 |
| 02:18 ET | 2291 | 0.0555 |
| 02:27 ET | 1455 | 0.05625 |
| 02:50 ET | 10000 | 0.0555 |
| 03:21 ET | 100 | 0.05465 |
| 03:26 ET | 3000 | 0.05475 |
| 03:30 ET | 6000 | 0.054772 |
| 03:50 ET | 55000 | 0.055 |
| 03:55 ET | 3658 | 0.0528 |
Nov 11, 2024
MediPharm Labs Sets Date to Report Third Quarter 2024 Financial Results, from 6:15AM ET on Monday Nov 11, 2024 by Dow Jones
6:15AM ET on Monday Nov 11, 2024 by Dow Jones
Oct 17, 2024
Press Release: MediPharm Labs Announces Departure of President and Co-Founder Keith Strachan, from 7:35AM ET on Thursday Oct 17, 2024 by Dow Jones
7:35AM ET on Thursday Oct 17, 2024 by Dow JonesMediPharm Labs Announces Departure of President and Co-Founder Keith Strachan, from 7:35AM ET on Thursday Oct 17, 2024 by Dow Jones
7:35AM ET on Thursday Oct 17, 2024 by Dow JonesPress Release: MediPharm Labs Announces Departure of President and Co-Founder Keith Strachan, from 7:35AM ET on Thursday Oct 17, 2024 by Dow Jones
7:35AM ET on Thursday Oct 17, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Medipharm Labs Corp | 32.9M | --- | --- |
Company Information
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.
Contact Information
- Headquarters
- 151 John StreetBARRIE, ON, Canada L4N 2L1
- Phone
- 705-719-7425
- Fax
- 705-719-7425
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $32.9M |
|---|---|
Revenue (TTM) | $37.8M |
Shares Outstanding | 411.1M |
Medipharm Labs Corp does not pay a dividend. | |
Beta | 0.99 |
EPS | $-0.04 |
Book Value | $0.13 |
P/E Ratio | --- |
Price/Sales (TTM) | 0.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -37.12% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
